ISRCTN92577199CompletedNot Applicable
Efficacy of inhaled DNase in admitted infants with RSV-bronchiolitis
Roche Nederland BV (Netherlands)0 sites222 target enrollmentStarted: September 12, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 222
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. RSV bronchiolitis with need for additional oxygen (saturation iÜ 92 %)
- •2. RSV-infection proven with rapid assay or culture
- •3. Age < 12 months
- •4. Admission on (medium care) ward
- •5. Study medication can be started within 24 hours
Exclusion Criteria
- •1. Premature birth (born < 32 weeks of gestation)
- •2. Congenital heart disease
- •3. Pre-existent lung disease (e.g. BPD or CF)
- •4. T-cel immune deficiency
- •5. Pre-treatment with systemic steroids
Investigators
Similar Trials
Completed
Not Applicable
Efficacy of inhaled DNase in children with an airway malacia and a lower respiratory tract infectioTracheobronchomalacia, lower respiratory tract disease (LRTD)RespiratoryUnspecified acute lower respiratory infectionISRCTN85366144Erasmus Medical Centre (Netherlands)40
Completed
Not Applicable
Efficacy of inhaled DNase in admitted infants with RSV-bronchiolitis.NL-OMON20249180
Completed
Not Applicable
Efficacy of inhaled DNase in children with an airway malacia and a lowerrespiratory tract infection.Tracheobronchomalacia and a lower respiratory tract infectionNL-OMON20292Erasmus MC-Sophia Children's Hospital40
Not yet recruiting
Phase 1
Double blind placebo controlled study for the role of budesonide in meconium aspiration syndromeCTRI/2019/06/019947Swami dayanand hospital
Completed
Phase 1
Inhaled budesonide in neonatal respiratory distress syndrome: is it beneficial?neonatal respiratory distressneonate ,respiratory distressTCTR20201228003mohamed shawky elfarargy120